Operator
Good day, and thank you for standing by. Welcome to the Accolade first-quarter 2022 earnings results call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session.
[Operator instructions] Please be advised that today s conference is being recorded. [Operator instructions] I would now like to hand the conference over to your speaker today, Todd Friedman. Please go ahead.
Todd Friedman
Senior Vice President, Investor Relations
Thanks, operator. Welcome, everyone, to our fiscal first-quarter earnings call. With me on the call today are our chief executive officer, Rajeev Singh; and our chief financial officer, Steve Barnes. Shantanu Nundy, our chief medical officer, will join us for the question-and-answer portion of the call later.
North American Morning Briefing: Stock Futures -2-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Accolade: Fiscal Q1 Earnings Snapshot
680news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 680news.com Daily Mail and Mail on Sunday newspapers.
(1) A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying Financial Tables. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures.”
(2) Percentages are calculated from accompanying Financial Tables and may differ from percentage change of numbers in Financial Highlights table due to rounding.
Financial Outlook
For the fiscal first quarter ending May 31, 2021, we expect:
Revenue between $54 million and $56 million
Adjusted EBITDA, a non-GAAP measure, between $(16) million and $(19) million
For the fiscal year ending February 28, 2022, we expect:
Revenue between $260 million and $265 million
Adjusted EBITDA, a non-GAAP measure, between $(38) million and $(42) million
Operator
Good day, and thank you for standing by. Welcome to the Accolade 4Q 21 earnings results conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to hand the conference over to your host, Todd Friedman with IR.
Thank you. You may begin.
Todd Friedman
Investor Relations
Thanks, operator. Welcome, everyone, to our fiscal fourth-quarter and year-end earnings call. With me today are our CEO, Rajeev Singh; and our CFO, Steve Barnes. Shantanu Nundy, our chief medical officer, will join us for the question-and-answer portion of the call.
Let me first start by saying I apologize, we actually omitted the Q4 table, although it has the summary numbers and the rest of the tables are correct in the release. So we ll issue an amended release shortly with the full table details for you. Before turning the call over to Rajeev, please note that we ll be discussing certain non-GAAP financial measures that we believe are important in